Cargando…
Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS)
Autores principales: | Lu, Lu, Xia, Shuai, Ying, Tianlei, Jiang, Shibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773045/ https://www.ncbi.nlm.nih.gov/pubmed/26954884 http://dx.doi.org/10.1038/emi.2015.37 |
Ejemplares similares
-
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
por: Xia, Shuai, et al.
Publicado: (2014) -
Urgent Call for Research on Middle East Respiratory Syndrome (MERS) in Korea
por: Cho, Sung-il
Publicado: (2015) -
The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
por: Arabi, Yaseen M., et al.
Publicado: (2016) -
The Middle East Respiratory Syndrome (MERS)
por: Azhar, Esam I., et al.
Publicado: (2019) -
Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
por: Channappanavar, Rudragouda, et al.
Publicado: (2015)